Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4A11 | Q02928 | 5/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28675638 | 0.85 | PLK1 (0.47) | TSHRTDP1 | |
| SCHEMBL1898058 | 0.83 | PPARA (0.36) | CYP4A11CYP4F2TSHRHTTSMN1; SMN2 | |
| SCHEMBL4458244 | 0.81 | ALDH1A1 (0.48) | TSHRHTTSMN1; SMN2TDP1HRH3 | |
| SCHEMBL27482835 | 0.80 | THRA (0.56) | — | |
| SCHEMBL6696391 | 0.78 | SRD5A2 (0.39) | TSHRHTTSMN1; SMN2 | |
| SCHEMBL10943813 | 0.78 | CES2 (0.39) | — | |
| SCHEMBL3974791 | 0.76 | GAA (0.50) | TSHRSMN1; SMN2HRH3 | |
| SCHEMBL10943780 | 0.76 | CES2 (0.41) | — | |
| SCHEMBL6692915 | 0.76 | SRD5A2 (0.41) | TSHRHTTSMN1; SMN2 | |
| SCHEMBL3677117 | 0.75 | FASN (0.36) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367743-B2 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | BASF SE (DE) | 2013-02-05 | — | — | US | disclosed |
| US-8367743-B2 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | BASF SE (DE) | 2013-02-05 | — | — | US | disclosed |
| US-20090104464-A1 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | IGM GROUP B.V. (NL) | 2009-04-23 | — | — | US | disclosed |
| US-20090104464-A1 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | IGM GROUP B.V. (NL) | 2009-04-23 | — | — | US | disclosed |
| WO-2009050116-A2 | ADHESION PROMOTING PHOTOINITIATORS FOR UV CURED COATINGS OVER METAL SURFACES | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |
| WO-2009050116-A2 | ADHESION PROMOTING PHOTOINITIATORS FOR UV CURED COATINGS OVER METAL SURFACES | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104464-A1 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | CDH1, PCNA, VCAM1 | CYP4A11 4662/4885CYP4F2 3785/4885TSHR 4170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.